Destiny Pharma: Funding, Investors & Team (Oct 2026)
Destiny Pharma is a cutting-edge pharmaceutical business that aims to create ground-breaking antimicrobial treatments. Our series of compounds, known as XF, work in a distinctive manner that sets them apart from all other antibacterial medications. Moreover, since the possibility of bacteria becoming resistant to XF is incredibly low, there are several potential benefits in using this approach to dealing with drug-resistant bacteria, which is a critical healthcare issue worldwide.
Destiny Pharma has raised $8.9M across 2 funding rounds on record, the most recent an undisclosed round of $8.9M announced in Mar 2023.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Destiny Pharma Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Destiny Pharma Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Destiny Pharma announced a Grant in Jul 2022; the amount was not disclosed.
8 months later, an undisclosed round of $8.9M was announced in Mar 2023.
Destiny Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Destiny Pharma Funding Compared to Other Biotechnology Startups
Destiny Pharma's latest round of $8.9M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Destiny Pharma in Biotechnology and Brighton
Companies Similar to Destiny Pharma
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Destiny Pharma Funding FAQs
What does Destiny Pharma do?
Destiny Pharma is a cutting-edge pharmaceutical business that aims to create ground-breaking antimicrobial treatments. Our series of compounds, known as XF, work in a distinctive manner that sets them apart from all other antibacterial medications. Moreover, since the possibility of bacteria becoming resistant to XF is incredibly low, there are several potential benefits in using this approach to dealing with drug-resistant bacteria, which is a critical healthcare issue worldwide.
How much funding has Destiny Pharma raised?
Destiny Pharma has raised $8.9M across 2 rounds on record. The most recent is an undisclosed round of $8.9M announced in Mar 2023.
When did Destiny Pharma last raise funding?
Destiny Pharma's most recent funding round on record is an undisclosed round of $8.9M, announced in Mar 2023.
Who founded Destiny Pharma?
FundedIQ lists William Love (Founder) at Destiny Pharma.
Where is Destiny Pharma headquartered?
Destiny Pharma is based in Brighton, East Sussex, United Kingdom.
How many employees does Destiny Pharma have?
Destiny Pharma is in the 11-50 employee band.
How does Destiny Pharma's funding compare to other Biotechnology startups?
Destiny Pharma's latest round of $8.9M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Destiny Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Destiny Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.